Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. On S, Rath CG, Lan M, Wu B, et al. Br J Haematol 2022;197:63-70.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

On S, Rath CG, Lan M, Wu B, et al. Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. Br J Haematol 2022;197:63-70.
PMID: 35174480